Related Experiment Video
Updated: Jul 20, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.4K
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against
Alena Kozlova1, Ildus Pateev1, Galina Shepelkova2
1Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia.
Vaccines
|November 26, 2024
Summary
New mRNA vaccine technology shows promise for tuberculosis prevention. Modifying mRNA cap structures enhances immunogenicity, but further research is needed to improve vaccine-induced protection against this deadly bacterial disease.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- Tuberculosis (TB) remains a significant global health threat, causing over 10 million new cases annually.
- Existing control measures have saved lives, but rising infection rates necessitate novel prevention strategies.
- Messenger RNA (mRNA) vaccines offer a promising avenue for antituberculosis vaccination, building on their success against viral infections.
Purpose of the Study:
- To investigate the impact of cotranscriptional capping conditions and cap structure on mRNA translation efficiency.
- To develop and evaluate a novel antituberculosis mRNA vaccine, mEpitope-ESAT6, incorporating optimized mRNA cap structures.
- To compare the immunogenicity and protective efficacy of the mEpitope-ESAT6 vaccine against the BCG vaccine.
Main Methods:
- Comprehensive experiments were conducted in HEK293T and DC2.4 cell lines to assess mRNA translation.
- Optimized cap structures were identified and utilized to create the mEpitope-ESAT6 mRNA vaccine.
- Immunogenicity and protective activity of mEpitope-ESAT6 were compared with the Bacillus Calmette-Guérin (BCG) vaccine in preclinical models.
Main Results:
- The study identified specific cap structures that significantly enhance mRNA translation.
- The developed mEpitope-ESAT6 vaccine demonstrated superior immunogenicity compared to the BCG vaccine.
- Despite increased immunogenicity, the mEpitope-ESAT6 vaccine did not confer enhanced protection against tuberculosis.
Conclusions:
- Modulating mRNA cap analogs is an effective strategy to enhance mRNA vaccine efficacy.
- While improved immunogenicity was achieved, further optimization is required to translate this into enhanced protection against tuberculosis.
- This research contributes to the ongoing development of advanced mRNA vaccine platforms for infectious diseases.
More Related Videos
06:38Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
897
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
2.0K
Related Concept Videos
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:16Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...